[H]C12CC3([H])C(C(=O)OC)C(OC)C(OC(=O)c4cc(OC)c(OC)c(OC)c4)CC3([H])CN1CCc1c2[nH]c2cc(OC)ccc12
Assay: DRUGMATRIX inhibits MAO-A using Kynuramine as substrate with a single protein target (Homologous). The assay is In vitro, with Binding as the type description and BTI-TN-5B1-4 as the cell type. Does the molecule work for this assay?